Canonical NF-κB signaling maintains corneal epithelial integrity and prevents corneal aging via retinoic acid by Qian Yu, Soma Biswas, Gang Ma, Peiquan Zhao, Baojie Li, Jing Li

Subjects: “…angiogenesis inhibitor…”
Get full text

Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth by Brian C. Stagg, Hironori Uehara, Nathan Lambert, Ruju Rai, Isha Gupta, Bryce Radmall, Taylor Bates, Balamurali K. Ambati

Subjects: “…VEGFR2, angiogenesis inhibitors, morpholinos, alternative polyadenylation…”
Get full text

Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs by Pierre Decazes, Samy Ammari, Antoine De Prévia, Léo Mottay, Littisha Lawrance, Younes Belkouchi, Baya Benatsou, Laurence Albiges, Corinne Balleyguier, Pierre Vera, Nathalie Lassau

Subjects: Get full text

Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report by Yu-Chien Lin, Kuo-Chang Wen, Pi-Lin Sung, Yu-Ting Chou, Phui-Ly Liew, Lin-Yu Chen, Rui-Lan Huang, Hung-Cheng Lai, Lu-Te Chang

Subjects: “…Angiogenesis inhibitor…”
Get full text

Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient by Camillo Porta, Camillo Porta, Alessandra Ferrari, Anna M. Czarnecka, Cezary A. Szczylik

Subjects: “…angiogenesis inhibitor…”
Get full text

Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma by Thi Bich Uyen Le, Thanh Chung Vu, Rebecca Zhi Wen Ho, Aldo Prawira, Lingzhi Wang, Boon Cher Goh, Hung Huynh

Subjects: Get full text

Bevacizumab, a vascular endothelial growth factor inhibitor, promotes orthodontic tooth movement in an experimental rat model by Hatem Abuohashish, Abdulaziz Alamri, Suliman Shahin, Dalal Almazrou, Taleb Alkhamis, Omar Omar

Subjects: “…Angiogenesis inhibitors…”
Get full text

Efficacy and Safety of Anlotinib in Overall and Disease-Specific Advanced Gynecological Cancer: A Real-World Study by Hong X, Qiu S, Wu X, Chen S, Chen X, Zhang B, He A, Xu Y, Wang J, Gao Y, Xu X, Sun L, Zhang Y, Xiang L, Zhou J, Guan Q, Zhu Y, Liu H, Xu H, Zhou Y, Chen B, Shen Y

Subjects: Get full text

Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance by Bahare Zarrin, Farzane Zarifi, Golnaz Vaseghi, Shaghayegh Haghjooy Javanmard

Subjects: “…Angiogenesis inhibitors…”
Get full text

Inhibition of EGF and CoCl2-Induced HIF-1α and VEGF Production in Triple Negative MDA-MB-468 Cells by Umbelliprenin: Unveiling the Role of PI3K/AKT/mTOR and MAPK Pathways by Roya Atabakhshian, Melina Moshirpour, Mohammad Hadi Farjoo, Shiva Ghafghazi, Seyed Ali Ziai*

Subjects: “…angiogenesis inhibitors…”
Get full text

Efficacy and safety of bevacizumab in patients with malignant melanoma: a systematic review and PRISMA-compliant meta-analysis of randomized controlled trials and non-comparative c... by Xiao Han, Xiao Han, Pu Ge, Siyu Liu, Dandan Yang, Jinzi Zhang, Xinpei Wang, Weiting Liang

Subjects: Get full text

Marine Cyanobacteria as Sources of Lead Anticancer Compounds: A Review of Families of Metabolites with Cytotoxic, Antiproliferative, and Antineoplastic Effects by Benjamín Robles-Bañuelos, Lorena María Durán-Riveroll, Edgar Rangel-López, Hugo Isidro Pérez-López, Leticia González-Maya

Subjects: “…angiogenesis inhibitor…”
Get full text

Osimertinib and Bevacizumab Cotreatment for Untreated EGFR-Mutated NSCLC With Malignant Pleural or Pericardial Effusion (SPIRAL II): A Single-Arm, Open-Label, Phase 2 Clinical Tria... by Makoto Hibino, MD, Osamu Hiranuma, MD, Yoshizumi Takemura, MD, PhD, Yuki Katayama, MD, Yusuke Chihara, MD, PhD, Taishi Harada, MD, Kohei Fujita, MD, PhD, Toshiyuki Kita, MD, PhD, Nobuyo Tamiya, MD, PhD, Takeshi Tsuda, MD, Shinsuke Shiotsu, MD, Yukihiro Tamura, MD, PhD, Takashi Aoyama, MD, Yoichi Nakamura, MD, PhD, Masaaki Terashima, MD, PhD, Yoshie Morimoto, MD, PhD, Kazuhiro Nagata, MD, PhD, Kenichi Yoshimura, PhD, Junji Uchino, MD, PhD, Koichi Takayama, MD, PhD

Subjects: “…Angiogenesis inhibitor…”
Get full text

Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy by Hong-My Nguyen, Kirsten Guz-Montgomery, Dipongkor Saha

Subjects: Get full text

Tumor angiogenesis regulators / by Gonzalez-Perez, Ruben R editor, Rueda, Bo R editor

Subjects:

Use of ranibizumab for the treatment of subretinal neovascularization in pathologic myopia: a prospective study by О.M. Blavatska, T.B. Kustry, A.R. Korol

Subjects: Get full text

CHOROIDAL OSTEOMA: CLINICAL AND DIAGNOSTIC FEATURES by A.A. YAROVOY, V.A. YAROVAYA, D.S. ASTARKHANOVA, S.S. KLEYANKINA

Subjects: Get full text

Renal Soluble Guanylate Cyclase Is Downregulated in Sunitinib‐Induced Hypertension by Jeannine Witte, Melanie Mühlbauer, Diana Braun, Antje Steinbach, Janine Golchert, Rainer Rettig, Olaf Grisk

Subjects: “…angiogenesis inhibitors…”
Get full text

Angiogenic inhibitor pre‐administration improves the therapeutic effects of immunotherapy by Mineyoshi Sato, Nako Maishi, Yasuhiro Hida, Aya Yanagawa‐Matsuda, Mohammad Towfik Alam, Jun Sakakibara‐Konishi, Jin‐Min Nam, Yasuhito Onodera, Satoshi Konno, Kyoko Hida

Subjects: “…angiogenesis inhibitors…”
Get full text

Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial by Mengru Cao, Hailing Lu, Shi Yan, Hui Pang, Lichun Sun, Chunhong Li, Xuesong Chen, Wei Liu, Jing Hu, Jian Huang, Ying Xing, Ningzhi Zhang, Yingqi Chen, Ting He, Danni Zhao, Yuanyuan Sun, Lin Zhao, Xiaomeng Liu, Li Cai

Subjects: Get full text